![]()
More and more novel therapies and treatments require the re-development of existing drugs. We’re enhancing drug formulation with our Premix™ medicines to match the current standard of care with products that are ready to use.
![]()
Surgical procedures invasivity and duration reduction and increased cost pressures on health systems are leading to a shift toward day surgery. Modern short and medium acting local anesthetics are our One Day Surgery® proposal to adapt the length and the conditions of anaesthesia to the novel surgical needs, allowing patients same day safe discharge.
![]()
We consider of outmost importance that patients when back home after surgery are again fully a citizen. This means that pain has to be managed at hospital as much as possible. Dual Spinal® is our development of an innovative pain killer drug to treat the acute pain after surgery at hospital, when inducing anaesthesia.
![]()
Enhance Intrathecal Therapy® is our promise to improve care in the neuromodulation.
We develop novel drugs and make available life-changing medicines to the largest number of patients and health care providers world-wide.
|